Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Spectral Medical Tigris Trial and Corporate Update Call

<< Previous

Bullboard Posts

Next >>

Comment by oilandgasmanon Dec 14, 2024 4:05pm

301 Views

Post# 36362628

RE:RE:Spectral Medical Tigris Trial and Corporate Update Call

Someplace in-between

Another hazy timeline with a financing announcement.

Half answers with zero hard trial or data information.

A half-hearted stab at convincing anyone who buys it still that enrollment is good.

I wouldn’t get my hopes up to much. I usually walk away from these calls with more questions about both the companies resistance to sharing news and the ability to recognize the News void most long loyal investors operate within.

Just a guess.

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly